asa guidelines for glp-1 drugs Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement GLP-1 and Anesthesia: Considerations and
Description
Low protein intake due to reduced appetite may also contribute to muscle loss and increased risk for sarcopenia especially among those with older age, sedentary behaviour and a lack of resistance/strength training
If symptoms are genuinely anxiety-related rather than medication side effects, they typically persist beyond the immediate post-injection period and occur independently of blood glucose levels or gastrointestinal symptoms
doi:10.1016/j.cmet.2013.04.008 2
GLP-1 agonists are incretin hormones produced by the enteroendocrine L-cells of the small bowel and colon
